Читать книгу Interventional Cardiology - Группа авторов - Страница 202

1 1 Tonino PAL, Fearon WF, De Bruyne B, et al. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study. J Am Coll Cardiol. 2010; 55:2816–21. doi:10.1016/j.jacc.2009.11.096

2 2 Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019; 100:106. doi:10.1093/eurheartj/ehz425

3 3 Wijns W, Kolh P, Danchin N, et al. Guidelines for myocardial revascularization. Kardiol Pol 2010; 68:S569–S638.

4 4 Gotberg M, Cook CM, Sen S, et al. The Evolving Future of Instantaneous Wave‐Free Ratio and Fractional Flow Reserve. J Am Coll Cardiol. 2017; 70:1379–402. doi:10.1016/j.jacc.2017.07.770

5 5 van de Hoef TP, Meuwissen M, Escaned J, et al. Fractional flow reserve as a surrogate for inducible myocardial ischaemia. Nature Reviews Cardiology 2013; 10:439–52. doi:10.1038/nrcardio.2013.86

6 6 Pijls NHJ, van Gelder B, Van der Voort P, et al. Fractional Flow Reserve. Circulation 1995; 92:3183–93. doi:10.1161/01.CIR.92.11.3183

7 7 Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary‐artery stenoses. N Engl J Med 1996; 334:1703–8. doi:10.1056/NEJM199606273342604

8 8 Rieber J, Jung P, Erhard I, et al. Comparison of pressure measurement, dobutamine contrast stress echocardiography and SPECT for the evaluation of intermediate coronary stenoses. The COMPRESS trial. Int J Cardiovasc Intervent 2009; 6:142–7. doi:10.1080/14628840410030504

9 9 Erhard I, Rieber J, Jung P, et al. Die Validierung der Fraktionalen Flussreserve bei Patienten mit koronarer Mehrgefäßerkrankung: ein Vergleich mit SPECT und Dobutamin‐Stressechokardiographie. Z Kardiol 2005; 94:321–7. doi:10.1007/s00392‐005‐0213‐6

10 10 Christou MAC, Siontis GCM, Katritsis DG, et al. Meta‐Analysis of Fractional Flow Reserve Versus Quantitative Coronary Angiography and Noninvasive Imaging for Evaluation of Myocardial Ischemia. The American Journal of Cardiology 2007; 99:450–6. doi:10.1016/j.amjcard.2006.09.092

11 11 Bech GJW, De Bruyne B, Pijls NHJ, et al. Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis : A Randomized Trial. Circulation 2001; 103:2928–34. doi:10.1161/01.CIR.103.24.2928

12 12 Pijls NHJ, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5‐year follow‐up of the DEFER Study. J Am Coll Cardiol. 2007; 49:2105–11. doi:10.1016/j.jacc.2007.01.087

13 13 Zimmermann FM, Ferrara A, Johnson NP, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non‐significant coronary stenosis: 15‐year follow‐up of the DEFER trial. Euro Heart J. 2015; 36:3182–8. doi:10.1093/eurheartj/ehv452

14 14 Tonino PAL, De Bruyne B, Pijls NHJ, et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. N Engl J Med. 2009; 360:213–24. doi:10.1056/NEJMoa0807611

15 15 De Bruyne B, Fearon WF, Pijls NHJ, et al. Fractional flow reserve‐guided PCI for stable coronary artery disease. N Engl J Med. 2014; 371:1208–17. doi:10.1056/NEJMoa1408758

16 16 De Bruyne B, Pijls NHJ, Kalesan B, et al. Fractional flow reserve‐guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012; 367:991–1001. doi:10.1056/NEJMoa1205361

17 17 Davies JE, Sen S, Dehbi H‐M, et al. Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. http://dxdoiorg/101056/NEJMoa1700445 2017; :NEJMoa1700445. doi:10.1056/NEJMoa1700445

18 18 Gotberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous Wave‐free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017; 376:1813–23. doi:10.1056/NEJMoa1616540

19 19 Coronary Revascularization Writing Group, Patel MR, Calhoon JH, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol. Published Online First: 14 December 2016. doi:10.1016/j.jacc.2016.10.034

20 20 Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol. Published Online First: March 2017. doi:10.1016/j.jacc.2017.02.001

21 21 Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol. 2012; 60:e44–e164. doi:10.1016/j.jacc.2012.07.013

22 22 Nijjer SS, Sen S, Petraco R, et al. Pre‐Angioplasty Instantaneous Wave‐Free Ratio Pullback Provides Virtual Intervention and Predicts Hemodynamic Outcome for Serial Lesions and Diffuse Coronary Artery Disease. JACC: Cardiovascular Interventions 2014; 7:1386–96. doi:10.1016/j.jcin.2014.06.015

23 23 Kikuta Y, Cook CM, Sharp ASP, et al. Pre‐Angioplasty Instantaneous Wave‐Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT Registry. JACC: Cardiovascular Interventions 2018; 11:757–67. doi:10.1016/j.jcin.2018.03.005

24 24 Pijls NHJ. Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow‐Up: A Multicenter Registry. Circulation 2002; 105:2950–4. doi:10.1161/01.CIR.0000020547.92091.76

25 25 Kocaman SA, Sahinarslan A, Arslan U, et al. The delta fractional flow reserve can predict lesion severity and long‐term prognosis. Atherosclerosis 2009; 203:178–84. doi:10.1016/j.atherosclerosis.2008.06.009

26 26 Doh J‐H, Nam C‐W, Koo B‐K, et al. Clinical Relevance of Poststent Fractional Flow Reserve After Drug‐Eluting Stent Implantation | Journal of Invasive Cardiology. 2020; 1–9.

27 27 Nam CW, Hur SH, Cho YK, et al. Relation of Fractional Flow Reserve After Drug‐Eluting Stent Implantation to One‐Year Outcomes. Am J Cardiol 2011; 107:1763–7. doi:10.1016/j.amjcard.2011.02.329

28 28 Fournier S, Ciccarelli G, Toth GG, et al. Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention. JAMA Cardiology 2019; 4:370–5. doi:10.1001/jamacardio.2019.0175

29 29 Agarwal SK, Kasula S, Hacioglu Y, et al. Utilizing Post‐Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long‐Term Outcomes. JACC: Cardiovascular Interventions 2016; 9:1022–31. doi:10.1016/j.jcin.2016.01.046

30 30 Wolfrum M, Fahrni G, De Maria GL, et al. Impact of impaired fractional flow reserve after coronary interventions on outcomes: a systematic review and meta‐analysis. BMC Cardiovasc Disord 2016; 16:1–9. doi:10.1186/s12872‐016‐0355‐7

31 31 Rimac G, Fearon WF, De Bruyne B, et al. Clinical value of post‐percutaneous coronary intervention fractional flow reserve value: A systematic review and meta‐analysis. Amer Heart Jnl 2017; 183:1–9. doi:10.1016/j.ahj.2016.10.005

32 32 Lee JM, Hwang D, Choi KH, et al. Prognostic Implications of Relative Increase and Final Fractional Flow Reserve in Patients With Stent Implantation. JACC: Cardiovascular Interventions 2018; 11:2099–109. doi:10.1016/j.jcin.2018.07.031

33 33 Piroth Z, Toth GG, Tonino PAL, et al. Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug‐Eluting Stent Implantation. Circulation Cardiovascular Interventions 2017; 10:346. doi:10.1161/CIRCINTERVENTIONS.116.005233

34 34 Ito T, Tani T, Fujita H, et al. Relationship between fractional flow reserve and residual plaque volume and clinical outcomes after optimal drug‐eluting stent implantation: Insight from intravascular ultrasound volumetric analysis. Int Jnl Cardiology 2014; 176:399–404. doi:10.1016/j.ijcard.2014.07.115

35 35 Rieber J, Schiele TM, Erdin P, et al. Fractional flow reserve predicts major adverse cardiac events after coronary stent implantation. Z Kardiol 2002; 91 Suppl 3:132–6.

36 36 Baranauskas A, Peace A, Kibarskis A, et al. FFR result post PCI is suboptimal in long diffuse coronary artery disease. EuroIntervention 2016; 12:1473–80. doi:10.4244/EIJ‐D‐15‐00514

37 37 Kim H‐L, Koo B‐K, Nam C‐W, et al. Clinical and Physiological Outcomes of Fractional Flow Reserve‐Guided Percutaneous Coronary Intervention in Patients With Serial Stenoses Within One Coronary Artery. JACC: Cardiovascular Interventions 2012; 5:1013–8. doi:10.1016/j.jcin.2012.06.017

38 38 Azzalini L, Poletti E, Demir OM, et al. Impact of Post‐Percutaneous Coronary Intervention Fractional Flow Reserve Measurement on Procedural Management and Clinical Outcomes: The REPEAT‐FFR Study. The Journal of Invasive Cardiology 2019; 31:229–34.

39 39 Matsumura M, Johnson NP, Fearon WF, et al. Accuracy of Fractional Flow Reserve Measurements in Clinical Practice: Observations From a Core Laboratory Analysis. JACC: Cardiovascular Interventions 2017; 10:1392–401. doi:10.1016/j.jcin.2017.03.031

40 40 Matsumura M, Maehara A, Davies JE, et al. Intensive Training and Real‐Time Quality Control by a Physiology Core Laboratory. Circulation Cardiovascular Interventions 2020; 13:1–3. doi:10.1161/CIRCINTERVENTIONS.120.009077

41 41 Flattery E, Rahim HM, Petrossian G, et al. Competency‐Based Assessment of Interventional Cardiology Fellows’ Abilities in Intracoronary Physiology and Imaging. Circulation Cardiovascular Interventions 2020; 13:1360–3. doi:10.1161/CIRCINTERVENTIONS.119.008760

42 42 Curzen N, Rana O, Nicholas Z, et al. Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study. Circulation Cardiovascular Interventions 2014; 7:248–55. doi:10.1161/CIRCINTERVENTIONS.113.000978

43 43 Nijjer SS, Sen S, Petraco R, et al. The Instantaneous wave‐Free Ratio (iFR) pullback: a novel innovation using baseline physiology to optimise coronary angioplasty in tandem lesions. Cardiovascular Revascularization Medicine: Including Molecular Interventions 2015; 16:167–71. doi:10.1016/j.carrev.2015.01.006

44 44 Nijjer SS, de Waard GA, Sen S, et al. Coronary pressure and flow relationships in humans: phasic analysis of normal and pathological vessels and the implications for stenosis assessment: a report from the Iberian‐Dutch‐English (IDEAL) collaborators. Euro Heart J. 2016; 37:2069–80. doi:10.1093/eurheartj/ehv626

45 45 Nijjer SS, Petraco R, van de Hoef TP, et al. Change in coronary blood flow after percutaneous coronary intervention in relation to baseline lesion physiology: results of the JUSTIFY‐PCI study. Circulation Cardiovascular Interventions 2015; 8:e001715. doi:10.1161/CIRCINTERVENTIONS.114.001715

46 46 Tarkin JM, Nijjer S, Sen S, et al. Hemodynamic response to intravenous adenosine and its effect on fractional flow reserve assessment: results of the Adenosine for the Functional Evaluation of Coronary Stenosis Severity (AFFECTS) study. Circulation Cardiovascular Interventions 2013; 6:654–61. doi:10.1161/CIRCINTERVENTIONS.113.000591

47 47 Echavarría‐Pinto M, Petraco R, van de Hoef TP, et al. Fractional flow reserve and minimum Pd/Pa ratio during intravenous adenosine infusion: very similar but not always the same. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Published Online First: 22 October 2014. doi:10.4244/EIJY14M10_09

48 48 Echavarria Pinto M, Gonzalo N, Ibanez B, et al. Low Coronary Microcirculatory Resistance Associated With Profound Hypotension During Intravenous Adenosine Infusion: Implications for the Functional Assessment of Coronary Stenoses. Circulation Cardiovascular Interventions 2014; 7:35–42. doi:10.1161/CIRCINTERVENTIONS.113.000659

49 49 Nijjer SS, Sen S, Petraco R, et al. Improvement in coronary haemodynamics after percutaneous coronary intervention: assessment using instantaneous wave‐free ratio. Heart (British Cardiac Society) 2013; 99:1740–8. doi:10.1136/heartjnl‐2013‐304387

50 50 Pijls NH, van Son JA, Kirkeeide RL, et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87:1354–67. doi:10.1161/01.CIR.87.4.1354

51 51 Johnson NP, Johnson DT, Kirkeeide RL, et al. Repeatability of Fractional Flow Reserve Despite Variations in Systemic and Coronary Hemodynamics. JACC: Cardiovascular Interventions 2015; 8:1018–27. doi:10.1016/j.jcin.2015.01.039

52 52 Perera D, Biggart S, Postema P, et al. Right atrial pressure: Can it be ignored when calculating fractional flow reserve and collateral flow index? J Am Coll Cardiol. 2004; 44:2089–91. doi:10.1016/j.jacc.2004.08.018

53 53 Van Belle EV, Rioufol G, Pouillot C, et al. Outcome Impact of Coronary Revascularization Strategy Reclassification With Fractional Flow Reserve at Time of Diagnostic Angiography Insights From a Large French Multicenter Fractional Flow Reserve Registry. Circulation 2014; 129:173–85. doi:10.1161/CIRCULATIONAHA.113.006646

54 54 Smits PC, Boxma‐de Klerk BM. Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction. N Engl J Med. 2017; 377:397–8. doi:10.1056/NEJMc1706275

55 55 Engstrøm T, Kelbaek H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST‐segment elevation myocardial infarction and multivessel disease (DANAMI‐3—PRIMULTI): an open‐label, randomised controlled trial. The Lancet (London, England) 2015; 386:665–71. doi:10.1016/S0140‐6736(15)60648‐1

56 56 Atti V, Gwon Y, Narayanan MA, et al. Multivessel Versus Culprit‐Only Revascularization in STEMI and Multivessel Coronary Artery Disease. JACC: Cardiovascular Interventions 2020; 13:1571–82. doi:10.1016/j.jcin.2020.04.055

57 57 Thim T, van der Hoeven NW, Musto C, et al. Evaluation and Management of Nonculprit Lesions in STEMI. JACC: Cardiovascular Interventions 2020; 13:1145–54. doi:10.1016/j.jcin.2020.02.030

58 58 Layland J, Oldroyd KG, Curzen N, et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non‐ST‐segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial. Euro Heart J. 2014; ehu338. doi:10.1093/eurheartj/ehu338

59 59 De Maria GL, Garcia‐Garcia HM, Scarsini R, et al. Novel Indices of Coronary Physiology. Circulation Cardiovascular Interventions 2020; 13:1596–13. doi:10.1161/CIRCINTERVENTIONS.119.008487

60 60 Gabara L, Hinton J, Gunn J, et al. Coronary Physiology Derived from Invasive Angiography: Will it be a Game Changer? Interventional Cardiology Review 2020; 15:1–8. doi:10.15420/icr.2019.25

61 61 Nijjer SS, de Waard GA, Sen S, et al. Coronary pressure and flow relationships in humans: phasic analysis of normal and pathological vessels and the implications for stenosis assessment: a report from the Iberian–Dutch–English (IDEAL) collaborators. Euro Heart J. 2016; 37:2069–80. doi:10.1093/eurheartj/ehv626

62 62 Sen S, Asrress KN, Nijjer S, et al. Diagnostic classification of the instantaneous wave‐free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration. Results of CLARIFY (Classification Accuracy of Pressure‐Only Ratios Against Indices Using Flow Study). J Am Coll Cardiol. 2013; 61:1409–20. doi:10.1016/j.jacc.2013.01.034

63 63 Sen S, Escaned J, Malik IS, et al. Development and Validation of a New Adenosine‐Independent Index of Stenosis Severity From Coronary Wave–Intensity Analysis. J Am Coll Cardiol. 2011; 59:1–12. doi:10.1016/j.jacc.2011.11.003

64 64 Petraco R, Escaned J, Sen S, et al. Classification performance of instantaneous wave‐free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry. EuroIntervention 2013; 9:91–101. doi:10.4244/EIJV9I1A14

65 65 Petraco R, Al‐Lamee R, Gotberg M, et al. Real‐time use of instantaneous wave‐free ratio: results of the ADVISE in‐practice: an international, multicenter evaluation of instantaneous wave‐free ratio in clinical practice. Amer Heart Jnl 2014; 168:739–48. doi:10.1016/j.ahj.2014.06.022

66 66 Escaned J, Echavarría‐Pinto M, Garcia‐Garcia HM, et al. Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave‐Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II). JACC: Cardiovascular Interventions 2015; 8:824–33. doi:10.1016/j.jcin.2015.01.029

67 67 Davies RPSNE‐PEPFE. Fractional Flow Reserve–Guided Revascularization. JACC: Cardiovascular Interventions 2013; 6:222–5. doi:10.1016/j.jcin.2012.10.014

68 68 Sen S, Asrress KN, Nijjer S, et al. Diagnostic classification of the instantaneous wave‐free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration. Results of CLARIFY (Classification Accuracy of Pressure‐Only Ratios Against Indices Using Flow Study). J Am Coll Cardiol. 2013; 61:1409–20. doi:10.1016/j.jacc.2013.01.034

69 69 van de Hoef TP, Nolte F, Damman P, et al. Diagnostic accuracy of combined intracoronary pressure and flow velocity information during baseline conditions: adenosine‐free assessment of functional coronary lesion severity. Circulation Cardiovascular Interventions 2012; 5:508–14. doi:10.1161/CIRCINTER‐VENTIONS.111.965707

70 70 Petraco R, van de Hoef TP, Nijjer S, et al. Baseline instantaneous wave‐free ratio as a pressure‐only estimation of underlying coronary flow reserve: results of the JUSTIFY‐CFR Study (Joined Coronary Pressure and Flow Analysis to Determine Diagnostic Characteristics of Basal and Hyperemic Indices of Functional Lesion Severity‐Coronary Flow Reserve). Circulation Cardiovascular Interventions 2014; 7:492–502. doi:10.1161/CIRCINTERVENTIONS.113.000926

71 71 De Waard G, Danad I, da Cunha RP, et al. Hyperemic FFR and baseline iFR have an equivalent diagnostic accuracy when compared to myocardial blood flow quantified by H2O15 PET perfusion imaging. J Am Coll Cardiol. 2014; 63:A1692. doi:10.1016/s0735‐1097(14)61695‐8

72 72 de Waard GA, Danad I, Petraco R, et al. Fractional flow reserve, instantaneous wave‐free ratio, and resting Pd/Pa compared with [15O]H2O positron emission tomography myocardial perfusion imaging: a PACIFIC trial sub‐study. Euro Heart J. 2018; 39:4072–81. doi:10.1093/eurheartj/ehy632

73 73 Davies JE, Sen S, Dehbi H‐M, et al. Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI. The New England Journal of Medicine 2017; 376:1824–34. doi:10.1056/NEJMoa1700445

74 74 van't Veer M, Pijls NHJ, Hennigan B, et al. Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal? J Am Coll Cardiol. 2017; 70:3088–96. doi:10.1016/j.jacc.2017.10.066

75 75 Ligthart J, Masdjedi K, Witberg K, et al. Validation of Resting Diastolic Pressure Ratio Calculated by a Novel Algorithm and Its Correlation With Distal Coronary Artery Pressure to Aortic Pressure, Instantaneous Wave–Free Ratio, and Fractional Flow Reserve. Circulation Cardiovascular Interventions 2018; 11:1–10. doi:10.1161/CIRCINTERVENTIONS.118.006911

76 76 Svanerud J, Ahn J‐M, Jeremias A, et al. Validation of a novel non‐hyperaemic index of coronary artery stenosis severity: the Resting Full‐cycle Ratio (VALIDATE RFR) study. EuroIntervention 2018; 14:806–14. doi:10.4244/EIJ‐D‐18‐00342

77 77 Leone AM, Martin‐Reyes R, Baptista SB, et al. The Multi‐center Evaluation of the Accuracy of the Contrast MEdium INduced Pd/Pa RaTiO in Predicting FFR (MEMENTO‐FFR) Study. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2016; 12:708–15. doi:10.4244/EIJV12I6A115

78 78 Leone AM, Scalone G, De Maria GL, et al. Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2015; 11:421–7. doi:10.4244/EIJY14M07_02

79 79 Ahmad Y, Vendrik J, Eftekhari A, et al. Determining the Predominant Lesion in Patients With Severe Aortic Stenosis and Coronary Stenoses. Circulation Cardiovascular Interventions 2019; 12:1409.

80 80 Warisawa T, Cook CM, Rajkumar C, et al. Safety of Revascularization Deferral of Left Main Stenosis Based on Instantaneous Wave‐Free Ratio Evaluation. JACC: Cardiovascular Interventions 2020; :1–10. doi:10.1016/j.jcin.2020.02.035

81 81 Indolfi C, Mongiardo A, Spaccarotella C, et al. The instantaneous wave‐free ratio (iFR) for evaluation of non‐culprit lesions in patients with acute coronary syndrome and multivessel disease. 2015; 178:46–54. doi:10.1016/j.ijcard.2014.03.210

82 82 Musto C, De Felice F, Rigattieri S, et al. Instantaneous wave‐free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST‐segment elevation myocardial infarction: The WAVE study. Amer Heart Jnl 2017; 193:63–9. doi:10.1016/j.ahj.2017.07.017

83 83 Thim T, Gotberg M, Frøbert O, et al. Nonculprit Stenosis Evaluation Using Instantaneous Wave‐Free Ratio in Patients With ST‐Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 2017; 10:2528–35. doi:10.1016/j.jcin.2017.07.021

84 84 Davies JE, Sen S, Dehbi H‐M, et al. Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI. N Engl J Med 2017; 376:1824–34. doi:10.1056/NEJMoa1700445

85 85 Petraco R, van de Hoef TP, Nijjer S, et al. Baseline instantaneous wave‐free ratio as a pressure‐only estimation of underlying coronary flow reserve: results of the JUSTIFY‐CFR Study (Joined Coronary Pressure and Flow Analysis to Determine Diagnostic Characteristics of Basal and Hyperemic Indices of Functional Lesion Severity‐Coronary Flow Reserve). Circulation Cardiovascular Interventions 2014; 7:492–502. doi:10.1161/CIRCINTERVENTIONS.113.000926

86 86 van de Hoef TP, van Lavieren MA, Damman P, et al. Physiological basis and long‐term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circulation Cardiovascular Interventions 2014; 7:301–11. doi:10.1161/CIRCINTERVENTIONS.113.001049

87 87 Lee JM, Hwang D, Park J, et al. Physiologic mechanism of discordance between instantaneous wave‐free ratio and fractional flow reserve: Insight from 13N‐ammonium positron emission tomography. International Journal of Cardiology 2017; 243:91–4. doi:10.1016/j.ijcard.2017.05.114

88 88 JM L, TM R, KH C, et al. Clinical Outcome of Lesions With Discordant Results Among Different Invasive Physiologic Indices ‐ Resting Distal Coronary to Aortic Pressure Ratio, Resting Full‐Cycle Ratio, Diastolic Pressure Ratio, Instantaneous Wave‐Free Ratio, and Fractional Flow Reserve. Circulation Journal: Official Journal of the Japanese Circulation Society 2019; 83:2210–21. doi:10.1253/circj.CJ‐19‐0230

89 89 Pijls NHJ, Klauss V, Siebert U, et al. Coronary pressure measurement after stenting predicts adverse events at follow‐up: a multicenter registry. Circulation 2002; 105:2950–4.

90 90 Hakeem A, Ghosh B, Shah K, et al. Incremental Prognostic Value of Post‐Intervention Pd/Pa in Patients Undergoing Ischemia‐Driven Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 2019; 12:2002–14. doi:10.1016/j.jcin.2019.07.026

91 91 Jeremias A, Davies JE, Maehara A, et al. Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study. JACC: Cardiovascular Interventions 2019; 12:1991–2001. doi:10.1016/j.jcin.2019.05.054

92 92 Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356:1503–16. doi:10.1056/NEJMoa070829

93 93 Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after PCI with drug‐eluting stents or coronary‐artery bypass surgery. N Engl J Med. 2011; 364:1016–26. doi:10.1056/NEJMoa1001508

94 94 Abdallah MS, Wang K, Magnuson EA, et al. Quality of Life After PCI vs CABG Among Patients With Diabetes and Multivessel Coronary Artery Disease: A Randomized Clinical Trial. JAMA 2013; 310:1581–90. doi:10.1001/jama.2013.279208

95 95 Ford TJ, Berry C. How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial. Interv Cardiol 2019; 14:76–82. doi:10.15420/icr.2019.04.R1

96 96 Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non‐Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Euro Heart J. 2020; 388:1459–21. doi:10.1093/eurheartj/ehaa503

97 97 Thomas J Ford MHF, Bethany Stanley M, Richard Good MD, et al. Stratified Medical Therapy Using Invasive Coronary Function Testing In Angina: CorMicA Trial. J Am Coll Cardiol. 2018; :1–53. doi:10.1016/j.jacc.2018.09.006

98 98 Kobayashi Y, Fearon WF. Invasive coronary microcirculation assessment‐‐current status of index of microcirculatory resistance. Circulation Journal : Official Journal of the Japanese Circulation Society 2014; 78:1021–8. doi:10.1253/circj.cj‐14‐0364

99 99 Yong AS, Layland J, Fearon WF, et al. Calculation of the Index of Microcirculatory Resistance Without Coronary Wedge Pressure Measurement in the Presence of Epicardial Stenosis. JACC: Cardiovascular Interventions 2013; 6:53–8. doi:10.1016/j.jcin.2012.08.019